Status:
TERMINATED
Strata Programmable CSF Shunt Valve Study
Lead Sponsor:
Johns Hopkins All Children's Hospital
Conditions:
Hydrocephalus
Eligibility:
All Genders
1-21 years
Brief Summary
The treatment of hydrocephalus is the most time consuming, and arguably the most important role of the pediatric neurosurgical service at most children's' hospitals. Despite many technological advance...
Detailed Description
Investigators intend to evaluate all patients 21 years old and younger with magnetically susceptible CSF shunts, specifically those with Strata (Medtronic, Dublin) valves implanted. All evaluations wi...
Eligibility Criteria
Inclusion
- Patients 21 years of age and younger
- With Strata valve CSF shunts
- Who are being evaluated by the All Children's Hospital (ACH) neurosurgical service as part of standard of care
Exclusion
- Patients older than 21 years of age
- Do not have a Strata CSF shunt valve
- Not patients of the All Children's Hospital neurosurgical service
Key Trial Info
Start Date :
April 1 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 8 2017
Estimated Enrollment :
95 Patients enrolled
Trial Details
Trial ID
NCT02737163
Start Date
April 1 2016
End Date
June 8 2017
Last Update
July 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Johns Hopkins All Children's Hospital
St. Petersburg, Florida, United States, 33701